Cerebrolysin
UnregulatedAlso known as: FPF 1070
Nootropic & NeuroprotectiveLast reviewed: April 28, 2026
A mixture of low-molecular-weight neuropeptides and amino acids derived from purified pig brain proteins. Approved as a drug in over 50 countries (including much of Europe and Asia) for stroke, traumatic brain injury, and Alzheimer's disease. One of the most clinically studied neuropeptide preparations in the world.
Mechanism of Action
Acts as a neurotrophic factor, mimicking the effects of BDNF, NGF, and other endogenous growth factors. Promotes neuronal survival, synaptic plasticity, and neurogenesis. Reduces excitotoxicity and oxidative stress in neural tissue. Crosses the blood-brain barrier due to its small molecular weight.
Common Uses
- Stroke recovery and rehabilitation
- Traumatic brain injury recovery
- Alzheimer's disease (approved in some countries)
- Cognitive enhancement
- Neuroprotection
Known Risks
- Derived from porcine brain — religious/ethical considerations for some
- Injection site reactions
- Rare allergic reactions
- Seizure risk at high doses (rare)
- Not FDA-approved — quality of gray-market sources varies significantly
Regulatory Status
Not FDA-approved in the United States. Approved as a prescription drug in 50+ countries including Germany, Austria, Russia, China, and most of Eastern Europe and Asia. Available in the US only as a research chemical or through international sources. Has the most robust clinical evidence base of any compound in the nootropic peptide category.
Common Protocols
Protocol information is for educational reference only. Dosing varies significantly by individual, condition, and physician guidance. Always work with a licensed healthcare provider.
Intramuscular or IV injection
Typical Dose
5–30 mL
Frequency
Once daily for 10–20 days (course-based)
Cycle Length
10–20 day course, 1–2x per year
Clinical protocols use course-based dosing rather than continuous use. IV administration preferred for neurological indications. IM is more practical for home use. Porcine-derived — not suitable for those with religious/ethical restrictions.
Related Compounds
Research References
This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any peptide therapy. Data is compiled from published research and regulatory sources and may not reflect the most recent developments.